ArticleAnnals of medicine and surgery (2012)2026
Medullary thyroid carcinoma with pheochromocytoma and cystic parathyroid degeneration in a ret-negative patient: a case report.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Multiple endocrine neoplasia type 2A (MEN2A) is a rare autosomal dominant hereditary cancer syndrome, predominantly caused by mutations of the Case presentation: We report the case of a 63-year-old female who was diagnosed with MTC and pheochromocytoma. and cystic parathyroid gland. Genetic workup was negative for Case discussion: MEN2A is associated with pathogenic germline variants in the RET proto-oncogene in approximately 95-99% of cases. Our patient, however, exhibited a MEN2A-like clinical phenotype in the absence of an identifiable RET mutation, with a pathogenic TMEM127 variant instead. Although TMEM127 is an established susceptibility gene for pheochromocytoma and paraganglioma, its association with the broader MEN2A phenotype remains unclear. This unusual genotype-phenotype discordance raises important questions regarding the potential role of alternative genetic pathways in MEN2-like syndromes and creates uncertainty regarding postoperative surveillance and the appropriate extent of screening and genetic counseling for family members. Conclusion: Our case represents an unusual scenario where the patient presents with a clinical phenotype of MEN2A but is
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.